by Birgit Johnston | Nov 2, 2020 | Fogarty Innovation
A message from Andrew Cleeland, CEO, Fogarty Innovation Here at Fogarty Innovation, we embrace the concept of re-imagining what already exists. That’s always been our cornerstone and remains so even as we ourselves evolve with the industry. In fact, that’s the theory... 
by Birgit Johnston | Oct 28, 2020 | Alliances, Thought Leadership
Optimism. It’s a word we may have heard or felt in limited quantities lately, and yet that was the overarching sentiment of the participants at the “Funding the Medtech Startup Journey” presentation, part of the virtual MedTech Strategist Investment & Partnering... 
by Birgit Johnston | Oct 27, 2020 | Success Stories
Securing financial backing is always a hot topic for startups, and never more so than today, when COVID-19 has upset the traditional landscape. That was the topic of “Medtech Innovation: The Post-COVID World of Innovation,” at the recent Transcatheter... 
by Birgit Johnston | Oct 27, 2020 | Success Stories
It’s always encouraging to hear about medtech entrepreneurs finding success. But have you ever wondered how they got there? The road, as you’d assume, is not straight, as nearly 100 FDA participants heard from successful entrepreneurs at an engaging, educational panel... 
by Birgit Johnston | Oct 27, 2020 | Alliances, Diversity, Thought Leadership
An industry that thrives on being innovative and disruptive has every reason to be a frontrunner in diversity and inclusion and the rewards it brings. That was the message conveyed during one of the six panels hosted by Fogarty Innovation, “Navigating the Call to... 
by Birgit Johnston | Oct 27, 2020 | Alliances, Policy, Thought Leadership
The show must go on, especially when it is something as important to the industry as the MDMA’s Medical Technology Executive Forum, now in its 13th year. Hosted by MDMA president and CEO Mark Leahey, the virtual event was extremely successful, highlighting how nimble... 